Article Details
Retrieved on: 2021-04-09 06:45:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Kymab is developing fully human monoclonal antibodies, with the aim of treating a wide variety of immune-mediated diseases and inflammatory ...
Article found on: businesscloud.co.uk
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here